Atopic Comorbidity Burden and Inpatient Outcomes in Eosinophilic Esophagitis: A Nationwide Analysis of Hospitalizations in the United States, 2016-2022

Background: Eosinophilic esophagitis (EoE) frequently coexists with atopic conditions, but the impact of atopy on inpatient outcomes and health care utilization remains unclear. This study evaluated national trends, hospitalization characteristics, endoscopic intervention rates, and the association between atopic comorbidities and clinical outcomes among adults hospitalized with EoE from 2016–2022. Methods: A retrospective analysis was conducted using the Nationwide Inpatient Sample (NIS) 2016 to 2022. Survey-weighted descriptive statistics, trend analyses, and multivariable survey logistic and linear regression models assessed associations between atopy and inpatient outcomes, including length of stay (LOS), total hospital charges, in-hospital mortality, and need for esophageal dilation. Subgroup analyses were performed for primary diagnosis EoE encounters and sex-stratified cohorts. Results: Among 41 million U.S. adult hospitalizations, 6,561 involved EoE, 24% had at least one atopic comorbidity. Atopic patients were younger but had slightly higher comorbidity burden. Atopy prevalence, LOS, and mortality rates remained stable over time, while hospitalization costs increased by approximately $2,825 per year. In adjusted models, atopy was not associated with mortality or charges. Comorbidity burden was the strongest predictor of mortality. Atopy was independently associated with shorter LOS, with a dose-response effect with increasing atopy burden. Among all EoE hospitalizations, 32.1% underwent inpatient EGD and 5.2% required esophageal dilation; atopy was not associated with dilation risk, whereas older age, lower socioeconomic status, and geographic region were significant predictors even when EoE is the principal reason for hospitalization. Conclusion: These findings improve understanding of inpatient EoE care and point to socioeconomic and regional disparities in management.

Authors

Institutions

Publication Details

Journal
Journal of Community Hospital Internal Medicine Perspectives
Published
2026-09-04
DOI
https://doi.org/10.55729/2000-9666.1644
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Atopic Comorbidity Burden and Inpatient Outcomes in Eosinophilic Esophagitis: A Nationwide Analysis of Hospitalizations in the United States, 2016-2022

Daniel Nyancho, Charles Anugwom, Yetunde Akande, Cherechi Nwabueze et al.
Journal of Community Hospital Internal Medicine Perspectives
Eosinophilic Esophagitis
article

Atopic Comorbidity Burden and Inpatient Outcomes in Eosinophilic Esophagitis: A Nationwide Analysis of Hospitalizations in the United States, 2016-2022

Daniel Nyancho, Charles Anugwom, Yetunde Akande, Cherechi Nwabueze, Eunice Omeludike, Ihunanya Kanu
article en

Abstract

Background: Eosinophilic esophagitis (EoE) frequently coexists with atopic conditions, but the impact of atopy on inpatient outcomes and health care utilization remains unclear. This study evaluated national trends, hospitalization characteristics, endoscopic intervention rates, and the association between atopic comorbidities and clinical outcomes among adults hospitalized with EoE from 2016–2022. Methods: A retrospective analysis was conducted using the Nationwide Inpatient Sample (NIS) 2016 to 2022. Survey-weighted descriptive statistics, trend analyses, and multivariable survey logistic and linear regression models assessed associations between atopy and inpatient outcomes, including length of stay (LOS), total hospital charges, in-hospital mortality, and need for esophageal dilation. Subgroup analyses were performed for primary diagnosis EoE encounters and sex-stratified cohorts. Results: Among 41 million U.S. adult hospitalizations, 6,561 involved EoE, 24% had at least one atopic comorbidity. Atopic patients were younger but had slightly higher comorbidity burden. Atopy prevalence, LOS, and mortality rates remained stable over time, while hospitalization costs increased by approximately $2,825 per year. In adjusted models, atopy was not associated with mortality or charges. Comorbidity burden was the strongest predictor of mortality. Atopy was independently associated with shorter LOS, with a dose-response effect with increasing atopy burden. Among all EoE hospitalizations, 32.1% underwent inpatient EGD and 5.2% required esophageal dilation; atopy was not associated with dilation risk, whereas older age, lower socioeconomic status, and geographic region were significant predictors even when EoE is the principal reason for hospitalization. Conclusion: These findings improve understanding of inpatient EoE care and point to socioeconomic and regional disparities in management.

Journal of Community Hospital Internal Medicine PerspectivesVol. 16(5)
Baptist Memorial Hospital (US), Piedmont Athens Regional (US), University Hospitals of Cleveland (US), John H. Stroger, Jr. Hospital of Cook County (US), Christus Health (US), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 8%
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.